Skip to main content
Clinical Trials/IRCT20181226042136N2
IRCT20181226042136N2RecruitingPhase 3

Evaluation of the effect of mesotherapy with a combination of biotin and dexpanthenol in the treatment of androgenetic alopecia in women

Esfahan University of Medical Sciences0 sites36 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
36

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • Having a female pattern hair loss
  • Do not use other hair loss treatments at the time of enrollment
  • Do not use temporary and permanent hair dye and curl or straighten hair
  • Do not use aspirin, warfarin, steroids, oral retinoids, hormones or cytotoxic drugs
  • Absence of pregnancy and lactation
  • Absence of high androgenic blood levels, irregular periods, acne and hirsutism, thromboembolic events, low ferritin blood levels and impaired TSH

Exclusion Criteria

  • Allergic reaction to the drug used
  • Failure to complete the course of treatment and failure to refer for follow-up, which results in a drawing on the case file or the patient
  • Local reactions such as abscesses, inflammation and cellulite at the injection site
  • The patient's decision not to participate in the study

Investigators

Similar Trials